Position in FTRE
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$1,657,138
-$1,376,447 QoQ
Shares Held
175,917
+0.0% QoQ
Ownership
0.186%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in FTRE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Sequoia Financial Advisors, LLC holds $24,441,881 across 36 Biotechnology names. FTRE ranks #3 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
14,898 | $6,652,552 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,189 | $2,463,948 | |
| 3 | FTRE |
Fortrea Holdings Inc.
This page
|
175,917 | $1,657,138 | |
| 4 | INCY |
Incyte Corp
|
16,377 | $1,541,403 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
4,560 | $1,508,767 | |
| 6 | ARGX |
Argenx SE
|
1,961 | $1,432,020 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
4,138 | $782,288 | |
| 8 | RPRX |
Royalty Pharma plc
|
15,670 | $751,689 |
All Filings in FTRE
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,657,138 | 175,917 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $3,033,585 | 175,860 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $1,479,899 | 175,760 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $870,225 | 176,159 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $1,316,395 | 174,357 | Shares | Sole | 2025-04-23 | |
| No filing history on record for this holder in this stock. | ||||||